News

ACORN expands market presence with commercialization of Guardian EDCT, the company’s electronic data capture system.

A partnership between Revolution Health and EmergingMed expands online services and helps match patients with the right clinical trials.

Brady introduces Labxpert v2.0 model to fulfill labeling requirements of the lab.

DSG is one of Ovation’s preferred providers for Phase I studies.

Nextrials’ revenues grow by 80 percent as industry adoption of Nextrial’ Prism accelerates, aided by growth in the medical device clinical trials market.

Logos Technologies and Exco InTouch integrate their EDC and SMS capabilities to speed up patient recruitment.

invivodata provides support to supplement approval of AMITIZA for irritable bowel syndrome with constipation in the United States.

Technology and services company Datatrak reports its 2008 first quarter results.

Former FDA Acting Commissioner and other industry experts to offer insight on turning Risk Evaluation and Mitigation Strategies theory into practice.

CTI Clinical Trial and Consulting Services and ASKA Research announce global collaboration in drug and medical device development, education services, and clinical trial management.

ACRO to collaborate with key stakeholders on efforts to enhance the clinical research enterprise.

Covance recognized for providing superior vaccine services to biopharmaceutical industry.

Mumbai investigative meeting conducted by Criterium, Inc. launches clinical study project in India for Thrombosis Research Institute.

Medidata’s clinical protocol authoring and trial design tool takes top honors in clinical trial and research category.

FDA will fill more than 1300 positions within the next several months.

SGS Opens Central & Eastern Europe Offices for Clinical Trial Management.

Clinsys Clinical Researchannounced the launch of Clinsys ALTERNA for customized Phase I–IV alternative solutions.

CDISC and HL7 combine to create Biomedical Research Integrated Domain Group Model.

Subscribe to EDC News

Subscribe to Lab Views

The Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland) received ?5 million from Spain's Agencia Espa?ola de Cooperaci?n Internacional, based in Madrid, to aid in the research and development of new, effective, and affordable drugs for neglected diseases, including Chagas disease, human African trypanosomiasis, and malaria. DNDi plans to develop two new malaria drugs by the end of the year and is looking to create between six and eight new drugs for neglected diseases by 2014.

Clinsys continues expansion of team and drug development and clinical trial design capabilities through therapeutically-aligned program strategists.

EDICT Initiative pinpoints areas in which clinical trials policies need improvement.

Oncology trials in the community are making strides for one research network.

A look at the latest industry news as of May 2008.

Synarc gives insight into what its like to open a Clinical Research Center in Hong Kong.

First call for proposals under the Innovative Medicines Initiative presented today in the presence of Commissioner Janez Potoènik and EFPIA President Arthur Higgins.

Tigermed Consulting joins Shanghai CRO Service Alliance, CROSA.